A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer

This study is currently recruiting participants.
Verified September 2013 by University of California, San Francisco
Sponsor:
Collaborator:
Janssen Services
Information provided by (Responsible Party):
Terence Friedlander, MD, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01637402
First received: July 6, 2012
Last updated: September 13, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)